Surface Oncology to Participate in the Cowen 43rd Annual Health Care Conference

March 1, 2023

https://www.globenewswire.com/news-release/2023/02/28/2617699/0/en/Surface-Oncology-to-Participate-in-the-Cowen-43rd-Annual-Health-Care-Conference.html

CAMBRIDGE, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Rob Ross, M.D., chief executive officer, will participate in a Novel Immuno-Oncology (IO) panel discussion at the Cowen 43rd Annual Health Care Conference taking place at the Marriott Copley Place in Boston, MA. 

Read more at globenewswire.com

Related news for (SURF)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.